Related Experiment Video
Updated: Jun 26, 2026
06:51
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
[Progress in the studies on small molecule IGF-1R inhibitors]
Yan Xu1, Guang-shu Wang, Wei Sun
1Department of Medicinal Chemistry, School of Pharmacy, Jilin University, Changchun 130021, China.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|January 9, 2009
Summary
Insulin-like growth factor 1 receptor (IGF-1R) signaling drives tumor growth. Inhibiting IGF-1R with novel small molecule tyrosine kinase inhibitors shows promise for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Insulin-like growth factor 1 receptor (IGF-1R) signaling is crucial for malignant cell behavior.
- IGF-1R activity inhibition can induce apoptosis in tumors.
Purpose of the Study:
- To review recent advancements in small molecule tyrosine kinase inhibitors (TKIs) targeting IGF-1R.
- To highlight the therapeutic potential of IGF-1R inhibitors in cancer treatment.
Main Methods:
- Literature review of preclinical and clinical studies.
- Focus on small molecule tyrosine kinase inhibitors (TKIs).
Main Results:
- Several IGF-1R targeted therapies, including antibodies and TKIs, have been developed.
- Preclinical characterization of IGF-1R TKIs demonstrates their potential.
Conclusions:
- Small molecule IGF-1R inhibitors represent a promising therapeutic strategy.
- Further development and clinical trials are warranted for these inhibitors.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...